Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 23.84B | 23.33B | 18.62B | 14.68B | 16.18B |
Gross Profit | 1.74B | 2.65B | 2.24B | 1.39B | 2.54B |
EBITDA | 1.16B | 2.02B | 977.00M | 430.00M | 1.46B |
Net Income | 200.00M | 986.00M | 1.02B | 138.00M | 932.00M |
Balance Sheet | |||||
Total Assets | 64.18B | 58.52B | 50.42B | 48.81B | 43.80B |
Cash, Cash Equivalents and Short-Term Investments | 6.87B | 3.20B | 8.29B | 11.72B | 10.43B |
Total Debt | 4.71B | 718.00M | 777.00M | 730.00M | 62.00M |
Total Liabilities | 20.91B | 13.94B | 12.13B | 11.71B | 7.62B |
Stockholders Equity | 43.27B | 44.58B | 38.29B | 37.10B | 36.18B |
Cash Flow | |||||
Free Cash Flow | 1.95B | -6.22B | -3.74B | 497.00M | -1.79B |
Operating Cash Flow | 4.27B | -4.38B | -1.82B | 1.75B | -1.00B |
Investing Cash Flow | -3.14B | -388.00M | -292.00M | -1.44B | -638.00M |
Financing Cash Flow | 2.59B | -304.00M | -325.00M | 442.00M | -234.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥303.17B | 11.83 | 3.03% | 12.29% | 59.92% | ||
74 Outperform | ¥162.68B | 19.56 | 5.08% | -7.59% | 18.77% | ||
71 Outperform | ¥202.13B | 11.52 | 4.45% | -8.67% | 40.83% | ||
69 Neutral | ¥111.18B | 16.93 | 3.66% | 2.61% | -9.19% | ||
69 Neutral | ¥97.19B | 17.05 | 2.69% | 10.88% | -29.60% | ||
64 Neutral | $10.64B | 16.52 | 6.24% | 2.15% | 3.01% | -28.89% | |
60 Neutral | ¥14.34B | 71.53 | 1.54% | 2.19% | -79.82% |